Since 2015, Thyroid Association of NZ (TANZi) has tried to engage endocrinologists and chemical pathologists who write NZ guidelines, lab testing policies and medical training so that issues for patients can be resolved. In 2018, TANZi told a local Member of… Read More ›
They say that history is written by the victors. Not always. Sometimes histories are written by advocates for the oppressed and disenfranchised. A common theme on our website is the need to see current practices and thyroid therapy challenges in… Read More ›
There’s no surprise that patients and doctors would disagree about the incidence rate of hypothyroid symptoms in a given patient. “We have an average of 7.2 symptoms per patient” says the cohort of 262 patients. “No, you have an average… Read More ›
This week, a thyroid patient from British Columbia posted an image of a piece of paper handed to her at a LifeLabs laboratory. LifeLabs BC was using this paper leaflet to explain to her why “Free T3 and Free T4… Read More ›
This post engages in a moral argument, not a scientific one. Thyroid pharmaceutical prejudice is part of a paradigm that is refusing to shift. We need to keep asking key questions and fight together for this shift. Look around you… Read More ›
By Tania S. Smith. Updated May 8, 2019 “Thyroid pharmaceutical prejudice” is simply a bias against one thyroid hormone pharmaceutical type in favor of another. Prejudice claims that a particular thyroid medication is intrinsically unsafe or ineffective, for all patients… Read More ›
One of Canada’s best thyroid doctors, Dr. Ron Matsusaki in Nova Scotia, has had his license to prescribe and treat thyroid suspended. His thyroid clinic in Digby has been under review for the past month, and the decision was announced… Read More ›
On April 8, 2018 The Canadian Society for Endocrinology and Metabolism (CSEM) made the happy announcement that they have made an edit to their prohibition of FT3 and FT4 testing in hypothyroidism. At first, patients were elated, hopeful, feeling like… Read More ›